{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/palliative-care-dyspnoea/management/known-cause-of-dyspnoea/","result":{"pageContext":{"chapter":{"id":"5b9d65e3-1fc3-558d-a95e-5e4ff147c7d7","slug":"known-cause-of-dyspnoea","fullItemName":"Scenario: Known cause of dyspnoea","depth":2,"htmlHeader":"<!-- begin field 1fb716c9-5508-4fd4-9e7c-d7ecbc4f7e46 --><h2>Scenario: Known cause of dyspnoea</h2><!-- end field 1fb716c9-5508-4fd4-9e7c-d7ecbc4f7e46 -->","summary":"Covers the management of people with dyspnoea of known cause in a palliative care setting.","htmlStringContent":"<!-- begin item c97e3762-13c3-47d5-ada7-36c6e3d9c9e9 --><!-- begin field 37aa4e8a-d077-4bfb-80c8-acbc015b15b8 --><p>From age 16 years onwards.</p><!-- end field 37aa4e8a-d077-4bfb-80c8-acbc015b15b8 --><!-- end item c97e3762-13c3-47d5-ada7-36c6e3d9c9e9 -->","topic":{"id":"20d4363b-caf3-55a9-beed-09266efa45f4","topicId":"73af552e-909d-456c-86d1-11f7a65040d8","topicName":"Palliative care - dyspnoea","slug":"palliative-care-dyspnoea","lastRevised":"Last revised in November 2020","chapters":[{"id":"0614f3a6-7238-5427-b059-9195b0cc2aa1","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"738e7584-0909-59c3-bd54-43100aed01fe","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"ea721a0d-cda2-5620-8e3f-61e76920b9b3","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"83260a2e-73f3-5abd-b049-c307d85d2cff","slug":"changes","fullItemName":"Changes"},{"id":"460710fb-be39-5a74-8adf-44beac90510f","slug":"update","fullItemName":"Update"}]},{"id":"a2422ca0-3b24-5c6e-81d8-07d257fdd44a","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2753bf62-a22c-5fb2-936c-554ef07426d4","slug":"goals","fullItemName":"Goals"},{"id":"65f25469-16d4-5c7f-b7bc-a6698ca61164","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"52a827c5-48de-5c0c-8dce-6c7eeeab720d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"cd3e39be-06ce-5750-a1f7-cbc06bb58756","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"50c51a08-6607-5699-96a8-d66cb532d2c5","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"05dc5599-43b4-5340-841b-3b3208f4b947","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"1fd04fd1-0023-5c48-9785-d9a54c7e2eb0","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"5a84982b-be4e-5901-a577-110f09001119","slug":"definition","fullItemName":"Definition"},{"id":"dab82422-38f4-5a30-b0db-ad2cbf33c2ab","slug":"prevalence-of-dyspnoea-in-palliative-care","fullItemName":"Prevalence of dyspnoea in palliative care"},{"id":"ea086054-ae8f-5666-9159-99b04676d230","slug":"causes-of-dyspnoea","fullItemName":"Causes of dyspnoea"},{"id":"c2601cd4-69b1-563f-870a-8110f4c24103","slug":"complications-of-dyspnoea","fullItemName":"Complications of dyspnoea"}]},{"id":"db288340-b73c-59b1-a8ba-4baec577b887","fullItemName":"Management","slug":"management","subChapters":[{"id":"62ed0387-08f9-5656-8079-a5fffee537f4","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"cdb4ccb3-9b96-5651-9950-6e2e0b8f4da0","slug":"symptomatic-treatment","fullItemName":"Scenario: Symptomatic treatment"},{"id":"5b9d65e3-1fc3-558d-a95e-5e4ff147c7d7","slug":"known-cause-of-dyspnoea","fullItemName":"Scenario: Known cause of dyspnoea"},{"id":"3b6b57e5-ba14-5311-bbf3-d996401c7dc6","slug":"end-of-life-care","fullItemName":"Scenario: End of life care"},{"id":"9983f052-047c-5346-adfc-b741909ce269","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"08f118cb-d39f-532d-b39f-fa97739c656d","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"22221f0a-e6f8-5976-bf6c-1024268816e0","slug":"oxygen","fullItemName":"Oxygen"},{"id":"25b01dc5-45e8-563d-872f-cfec63e33029","slug":"opioids","fullItemName":"Opioids"},{"id":"b7f561a2-0802-545a-b7d1-db218387a6e5","slug":"benzodiazepines","fullItemName":"Benzodiazepines"}]},{"id":"9f0bdd3b-82e3-5cbb-908f-d36a887457a8","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5c3c7cfe-04b9-5ac4-9255-be56a20c7b5c","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"3aa322d7-2279-512c-93a7-55426d21da21","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b889ecee-814d-5e79-b596-a024fbee0acf","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7e27fb69-52fd-5ddc-8f84-6164bb8615d0","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"c1800f44-6de2-534a-a4ff-32b8b5cf6e24","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6b7633c0-45a5-5a2e-b564-f185c2b9ef5f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"2d28faa0-4a5f-565b-a431-6339d01f6e91","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"db288340-b73c-59b1-a8ba-4baec577b887","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"3feda63d-1a93-5d6b-bfe3-c346fbffd002","slug":"managing-dyspnoea-of-known-cause","fullItemName":"Managing dyspnoea of known cause","depth":3,"htmlHeader":"<!-- begin field 3ce66779-ff4c-4680-9437-c15d7d757c09 --><h3>How should I manage dyspnoea of known cause in palliative care?</h3><!-- end field 3ce66779-ff4c-4680-9437-c15d7d757c09 -->","summary":null,"htmlStringContent":"<!-- begin item 156a5e04-9c7a-4529-9794-b25d855e924f --><!-- begin field 3deb1b5d-4957-44ef-a628-20d9301fe850 --><ul><li><strong>In all cases:</strong><ul><li>Consider <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/management/symptomatic-treatment/#simple-measures-to-help-dyspnoea\">simple measures</a> to relieve dyspnoea.</li><li>Consider symptomatic treatment if appropriate. See <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/management/symptomatic-treatment/\">Scenario: Symptomatic treatment</a>.</li></ul></li><li><strong>With the person and their carers and family, determine what management interventions are appropriate for the underlying cause of the dyspnoea and the stage of illness. These may include:</strong><ul><li>Treatment of reversible causes in primary care, such as asthma or chronic obstructive pulmonary disease (COPD).</li><li>Referral for treatment of the underlying cancer, if needed (for example radiotherapy to a tumour, drainage of a pleural effusion).</li><li>Referral if the cause of dyspnoea is not directly related to the underlying cancer, but is more appropriately managed in secondary care (for example worsening COPD).</li><li>Emergency treatment or admission to hospital (for example acute airway obstruction due to tumour or superior vena cava obstruction).</li></ul></li><li><strong>If in doubt as to whether treatment of the underlying illness is appropriate,</strong><strong>seek specialist advice</strong>.</li><li><strong>For immediate emergency management:</strong><ul><li>Sit the person upright.</li><li>Ensure a flow of cool air to the face.</li><li>Stay with the person.</li><li>Check oxygen saturation if a pulse oximeter is available. Start 24% oxygen if the saturation is 90% or less.</li><li>If the person develops stridor due to acute airway obstruction by a malignant cause, or superior vena cava obstruction, corticosteroid use may be beneficial in this situation but initiation should ideally be discussed with a palliative care consultant.</li><li>However, if specialist advice is not available, when needed, consider:<ul><li>Giving a single oral dose of dexamethasone 16 mg immediately, if the person can swallow. If they are unable to take oral medication, administer the dose via the intramuscular, subcutaneous (off-label route), or intravenous (IV) route (IV administration may be more difficult in primary care and should be given as a slow injection over 2 minutes).</li><li>If dexamethasone is not available, giving prednisolone 60 mg orally.</li><li>Arranging immediate admission to hospital if appropriate. However, if hospital admission is not appropriate, discuss ongoing management with an appropriate specialist.</li></ul></li></ul></li><li><strong>Separate CKS topics deal with the management of common non-malignant causes of dyspnoea. </strong>These can often be managed in primary care, but in some cases admission to hospital or secondary care advice may be necessary. For more information, see the CKS topics on:<ul><li><a class=\"topic-reference external-reference\" href=\"/topics/anaemia-iron-deficiency/\">Anaemia - iron deficiency</a></li><li><a class=\"topic-reference external-reference\" href=\"/topics/angina/\">Angina</a></li><li><a class=\"topic-reference external-reference\" href=\"/topics/asthma/\">Asthma</a></li><li><a class=\"topic-reference external-reference\" href=\"/topics/atrial-fibrillation/\">Atrial fibrillation</a></li><li><a class=\"topic-reference external-reference\" href=\"/topics/chest-infections-adult/\">Chest infections - adult</a></li><li><a class=\"topic-reference external-reference\" href=\"/topics/chronic-obstructive-pulmonary-disease/\">Chronic obstructive pulmonary disease</a></li><li><a class=\"topic-reference external-reference\" href=\"/topics/heart-failure-chronic/\">Heart failure - chronic</a></li></ul></li></ul><!-- end field 3deb1b5d-4957-44ef-a628-20d9301fe850 --><!-- end item 156a5e04-9c7a-4529-9794-b25d855e924f -->","subChapters":[{"id":"fc2d5066-a3e1-5e79-98f0-0d6c43a004e6","slug":"basis-for-recommendation-51a","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 819391d3-c068-4dd6-9da8-10c7bd75d853 --><h4>Basis for recommendation</h4><!-- end field 819391d3-c068-4dd6-9da8-10c7bd75d853 -->","summary":null,"htmlStringContent":"<!-- begin item 51a5e245-bb04-42e2-b4b8-6213ce660a8d --><!-- begin field 754943f4-a083-4e78-9b81-77f054568b00 --><p>These recommendations are pragmatic advice based on palliative care guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">International Association for Hospice and Palliative Care, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">NHMRC, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">NHS Scotland, 2015</a>], expert opinion in palliative care textbooks [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Twycross et al, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Regnard, 2010</a>], and expert opinion from reviewers of this CKS topic.</p><h5>Emergency management of acute airway obstruction by a malignant cause or superior vena cava obstruction</h5><ul><li>CKS has reviewed the palliative care literature and feedback from expert reviewers of this topic and has made recommendations based on this expert opinion. The drugs and doses recommended are based on expert opinion in a guideline on breathlessness in palliative care [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">NHS Lothian, 2010</a>].</li></ul><!-- end field 754943f4-a083-4e78-9b81-77f054568b00 --><!-- end item 51a5e245-bb04-42e2-b4b8-6213ce660a8d -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}